These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23815891)

  • 1. Improving stroke prevention in patients with atrial fibrillation.
    Arts DL; Abu-Hanna A; Büller HR; Peters RJ; Eslami S; van Weert HC
    Trials; 2013 Jul; 14():193. PubMed ID: 23815891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial.
    Arts DL; Abu-Hanna A; Medlock SK; van Weert HC
    PLoS One; 2017; 12(2):e0170974. PubMed ID: 28245247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.
    Brandes A; Overgaard M; Plauborg L; Dehlendorff C; Lyck F; Peulicke J; Poulsen SV; Husted S
    Clin Cardiol; 2013 Jul; 36(7):427-32. PubMed ID: 23670894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From assessment to improvement of elderly care in general practice using decision support to increase adherence to ACOVE quality indicators: study protocol for randomized control trial.
    Eslami S; Askari M; Medlock S; Arts DL; Wyatt JC; van Weert HC; de Rooij SE; Abu-Hanna A
    Trials; 2014 Mar; 15():81. PubMed ID: 24642339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
    Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.
    Ermini G; Perrone V; Veronesi C; Degli Esposti L; Di Pasquale G
    Vasc Health Risk Manag; 2017; 13():239-246. PubMed ID: 28740396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
    Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
    Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
    Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.
    Miyazawa K; Ogawa H; Mazurek M; Shantsila E; Lane DA; Wolff A; Akao M; Lip GYH
    Circ J; 2019 Nov; 83(12):2434-2442. PubMed ID: 31694989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
    Apenteng PN; Murray ET; Holder R; Hobbs FD; Fitzmaurice DA;
    BMC Cardiovasc Disord; 2013 Apr; 13():31. PubMed ID: 23617744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study).
    Karlsson LO; Nilsson S; Bång M; Nilsson L; Charitakis E; Janzon M
    PLoS Med; 2018 Mar; 15(3):e1002528. PubMed ID: 29534063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.
    Bajorek B; Magin P; Hilmer S; Krass I
    BMC Health Serv Res; 2014 Feb; 14():55. PubMed ID: 24507462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.
    Hua H; Sur N; Lee L; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105474. PubMed ID: 33242786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.